RANKL confers protection against cell death in precision-cut lung slices
- PMID: 36388105
- PMCID: PMC9659591
- DOI: 10.3389/fphys.2022.1029697
RANKL confers protection against cell death in precision-cut lung slices
Abstract
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally and constitutes a major health problem. The disease is characterized by airflow obstructions due to chronic bronchitis and/or emphysema. Emerging evidence suggests that COPD is the result of impaired epithelial repair. Motivated by the need for more effective treatments, we studied whether receptor activator of nuclear factor κ-Β ligand (RANKL) contributed to epithelial repair, as this protein has been implicated in epithelial regeneration of breast and thymus. To do so, we used precision-cut lung slices prepared from mouse tissue-viable explants that can be cultured ex vivo for up to a few days while retaining features of lung tissue. Slices were cultured with 10, 100, or 500 ng/ml of mouse RANKL for 24 h. We first found RANKL activated nuclear factor κ-Β signaling, which is involved in cellular stress responses, without affecting the general viability of slices. Cell proliferation, however, was not altered by RANKL treatment. Interestingly, RANKL did reduce cell death, as revealed by TUNEL stainings and profiling of apoptosis-related proteins, indicating that it contributes to repair by conferring protection against cell death. This study improves our understanding of lung repair and could create new opportunities for developing COPD treatments.
Keywords: OPGL; TRANCE; chronic bronchitis; emphysema; explant culture; tissue regeneration.
Copyright © 2022 Ruigrok, Roest, Frijlink, Olinga, Hinrichs and Melgert.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Elastase-Induced Parenchymal Disruption and Airway Hyper Responsiveness in Mouse Precision Cut Lung Slices: Toward an Ex vivo COPD Model.Front Physiol. 2017 Jan 4;7:657. doi: 10.3389/fphys.2016.00657. eCollection 2016. Front Physiol. 2017. PMID: 28101062 Free PMC article.
-
Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene.Biochim Biophys Acta. 1999 Apr 14;1445(1):134-41. doi: 10.1016/s0167-4781(99)00032-9. Biochim Biophys Acta. 1999. PMID: 10209265
-
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.Bone. 1999 Nov;25(5):517-23. doi: 10.1016/s8756-3282(99)00210-0. Bone. 1999. PMID: 10574571
-
A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. doi: 10.1006/bbrc.1999.0252. Biochem Biophys Res Commun. 1999. PMID: 10080918 Review.
-
Novel aspects of pathogenesis and regeneration mechanisms in COPD.Int J Chron Obstruct Pulmon Dis. 2015 Jun 2;10:995-1013. doi: 10.2147/COPD.S82518. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26082624 Free PMC article. Review.
Cited by
-
Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis.Lung. 2024 Jun;202(3):331-342. doi: 10.1007/s00408-024-00691-5. Epub 2024 Apr 20. Lung. 2024. PMID: 38642135 Free PMC article.
References
LinkOut - more resources
Full Text Sources